LSM4 was found to be related to diverse cancer-type signaling pathways, such as “Stem cells aberrant Wnt signaling in medulloblastoma stem cells”, “Mechanism of resistance to EGFR inhibitors in lung cancer”, and “Mechanism of drug resistance in multiple myelomas”, suggesting its important role in cancer development. This evidence concerns the gene EGFR and lung carcinoma.